RNF213 and multiminicore myopathy: A major breakthrough in elucidating MMD’s genetic basis occurred in 2011, when genome-wide association studies in East Asian populations identified ring finger protein 213 (RNF213), also known as mysterin, as the first susceptibility gene [5,6,7].